← Browse by Condition
Medical Condition

thalassemia major

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT05776173
Recruiting

Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia

Enrollment
10 pts
Location
China
Sponsor
Shanghai BDgene Co., Ltd.
View Trial →